Compare
ASTH vs HCA vs THC vs EHC
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| ASTH | HCA | THC | EHC | |
|---|---|---|---|---|
| Price | $34.50 | $494.99 | $283.33 | $137.54 |
| 1-day | -11.56% | -2.46% | -1.09% | -2.64% |
| YTD | +39.06% | +6.03% | +42.58% | +29.58% |
| 1 year | +3.79% | +4.60% | +35.81% | +19.29% |
| 3 years | +13.82% | +119.64% | +433.68% | +119.85% |
| Market cap | $1.9B | $103.4B | $22.6B | $13.5B |
| P/E | 31.9 | 16.4 | 8.2 | 21.5 |
| P/S | 0.49 | 1.31 | 1.02 | 2.13 |
| P/B | 2.25 | — | 4.14 | 5.03 |
| Revenue growth | +35.10% | +5.80% | +6.20% | +9.40% |
| EPS growth | +440.00% | +16.50% | +134.50% | +21.00% |
| Gross margin % | 11.0 | — | — | — |
| Net margin % | 1.4 | 8.6 | 13.1 | 10.2 |
| ROE % | 6.2 | — | 53.3 | 24.0 |
| Debt / equity | 1.08 | — | 2.43 | 0.97 |
| FCF yield % | 5.2 | 5.8 | 14.8 | 3.4 |
| Dividend yield % | — | 0.62 | — | 0.41 |
| Beta | 0.59 | 0.22 | 0.55 | -0.04 |
| RSI (14) | 39.8 | 62.2 | 60.2 | 63.7 |
| Technical rating |